GlassScriptPhysician profile
Narender Bharaj
NPI 1083682074
$1,454.75
in general payments reported to CMS, 2019-2025
19 companies · $260 in 2025
The $260 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $30.82 · 2021: $149 · 2022: $76.37 · 2023: $383 · 2024: $59.09 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $702.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $476.61 | 2019-2025 | Apligraf, Puraply, Affinity |
| Novartis Pharmaceuticals Corporation | $219.23 | 2019-2023 | |
| Lilly USA, LLC | $148.88 | 2019-2023 | Mounjaro, Jardiance, Trulicity |
| Janssen Products, LP | $99.99 | 2021 | |
| Astellas Pharma US INC | $93.09 | 2019 | |
| Sumitomo Pharma America, INC. | $88.90 | 2023 | Aptiom |
| Janssen Pharmaceuticals, INC | $74.86 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $41.54 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $39.09 | 2019-2020 | |
| Pfizer INC. | $24.90 | 2019 | |
| Abbvie INC. | $22.58 | 2023 | Vraylar |
| Gilead Sciences, INC. | $21.20 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.20 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.27 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $15.18 | 2023 | Rexulti |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14.99 | 2023 | Grafix Pl |
| Teva Pharmaceuticals USA, INC. | $14.31 | 2024 | Austedo Xr |
| Exact Sciences Corporation | $13.77 | 2023 | Cologuard Collection Kit |
| Avanir Pharmaceuticals, INC. | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narender Bharaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.